Analyst Price Targets — SANA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 14, 2026 1:04 pm | Martin Fan | Wedbush | $7.00 | $3.64 | TheFly | Sana Biotechnology price target raised to $7 from $6 at Wedbush |
| March 13, 2026 5:05 pm | Maxwell Skor | Morgan Stanley | $12.00 | $3.36 | StreetInsider | Morgan Stanley Reiterates Overweight Rating on Sana Biotechnology (SANA) after "meaningful platform level de-risking event" |
| March 4, 2026 11:41 am | Emily Bodnar | H.C. Wainwright | $7.00 | $3.85 | StreetInsider | Sana Biotechnology (SANA) PT Lowered to $7 at H.C. Wainwright |
| October 30, 2025 10:23 am | — | JMP Securities | $8.00 | $5.37 | TheFly | Sana Biotechnology price target raised to $8 from $5 at Citizens JMP |
| November 5, 2024 11:41 am | Emily Bodnar | H.C. Wainwright | $8.00 | $3.39 | StreetInsider | Sana Biotechnology (SANA) PT Lowered to $8 at H.C. Wainwright |
| January 16, 2024 6:05 am | Emily Bodnar | H.C. Wainwright | $12.00 | $6.36 | StreetInsider | H.C. Wainwright Upgrades Sana Biotechnology (SANA) to Buy |
Latest News for SANA
Sana Biotechnology, Inc. (NASDAQ: SANA - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eight research firms that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on the company.
Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript
Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Shared 12-month clinical results of ongoing UP421 type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression are safe and well-tolerated, evade detection by the immune system, and continue to function one year post-transplant
SEATTLE, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in March. The presentations will feature a business overview and update.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SANA.
U.S. House Trading
No House trades found for SANA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.